{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:28:56Z","timestamp":1761560936721,"version":"3.40.3"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3895,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>In chronic liver disease associated with histological necroinflammation, clinical severity is frequently greater in those with higher grades of activity. Conventional wisdom assumes that necroinflammation is mild or absent in patients with end-stage hepatitis B virus (HBV) cirrhosis due to the frequent presence of mildly elevated aminotransferase levels, the absence of hepatitis B e antigen (HBeAg), and low or undetectable HBV deoxyribonucleic acid (DNA) levels. However, a histopathologic analysis of such patients has not been undertaken. The aims of this study were 1) to assess severity and histological features of inflammation, 2) to correlate the severity of inflammation with biochemical and virologic parameters, and 3) to define the relationship between inflammation and clinical severity in explanted livers from patients undergoing liver transplantation for HBV cirrhosis. Characteristics of 34 consecutive patients undergoing liver transplantation for HBV cirrhosis were correlated with inflammation and immunohistological findings in the explanted livers. High-grade inflammation (grades 3 and 4) was found in many cases (47.1% interface hepatitis; 14.8% lobular inflammation; and 20.6% portal inflammation). The presence of positive cytoplasmic staining for hepatitis B core antigen (HBcAg) was associated with grade 3 or 4 interface hepatitis (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= .046) and lobular hepatitis (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= .005). There was no correlation between inflammatory activity and age, Asian ethnicity, aminotransferase levels, total bilirubin levels, HBeAg seropositivity, and detectable HBV DNA level. Patients with high-grade inflammation had greater degrees of hepatic decompensation. In conclusion, high-grade inflammation is common in end-stage HBV cirrhosis, but it is not readily detected by biochemical and virologic parameters. High-grade inflammation is associated with a greater degree of hepatic decompensation.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.20328","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T22:23:00Z","timestamp":1103754180000},"page":"82-88","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Histopathology and Clinical Correlates of End-Stage Hepatitis B Cirrhosis: a Possible Mechanism to Explain the Response to Antiviral Therapy"],"prefix":"10.1097","volume":"11","author":[{"given":"Samuel H.","family":"Sigal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aftab","family":"Ala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabera","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Bodian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D.","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry C.","family":"Bodenheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swan N.","family":"Thung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20250326","first-page":"1196","article-title":"The role of HBV DNA and liver histopathology in HBsAg carriers.","volume":"44","author":"Agalar","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"R2-14-20250326","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/gut.32.3.294","article-title":"Natural history and prognostic factors for chronic hepatitis type B.","volume":"32","author":"Fattovich","year":"1991","journal-title":"Gut"},{"key":"R3-14-20250326","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(86)80491-3","article-title":"Chronic hepatitis B virus infection, viral replication and patterns of inflammatory activity: serological, clinical and histological correlations.","volume":"3","author":"Paz","year":"1986","journal-title":"J Hepatol"},{"key":"R4-14-20250326","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0140-6736(97)09391-4","article-title":"Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis Be antigen.","volume":"351","author":"ter Borg","year":"1998","journal-title":"Lancet"},{"key":"R5-14-20250326","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0676.1997.tb00785.x","article-title":"Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B?","volume":"17","author":"Zavaglia","year":"1997","journal-title":"Liver"},{"key":"R6-14-20250326","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-94-6-744","article-title":"Seroconversion from hepatitis B e antigen to antibody in chronic hepatitis type B hepatitis.","volume":"94","author":"Hoofnagle","year":"1981","journal-title":"Ann Intern Med"},{"key":"R7-14-20250326","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0016-5085(80)90130-4","article-title":"Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.","volume":"79","author":"Realdi","year":"1980","journal-title":"Gastroenterology"},{"key":"R8-14-20250326","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840050315","article-title":"Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.","volume":"5","author":"Chu","year":"1985","journal-title":"Hepatology"},{"key":"R9-14-20250326","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/hep.1840010604","article-title":"Dane particle DNA polymerase and HBeAg: impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver disease.","volume":"1","author":"Andres","year":"1981","journal-title":"Hepatology"},{"key":"R10-14-20250326","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/gut.24.2.143","article-title":"Relationship between HBV-specific DNA polymerase and HBe antigen antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.","volume":"24","author":"Craxi","year":"1983","journal-title":"Gut"},{"key":"R11-14-20250326","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infectionnatural history and clinical consequences.","volume":"350","author":"Ganem","year":"2004","journal-title":"N Engl J Med"},{"key":"R12-14-20250326","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/BF02100141","article-title":"Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg.","volume":"41","author":"Mangia","year":"1996","journal-title":"Dig Dis Sci"},{"key":"R13-14-20250326","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJM199605303342202","article-title":"Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.","volume":"334","author":"Niederau","year":"1996","journal-title":"N Engl J Med"},{"key":"R14-14-20250326","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hep.1840060203","article-title":"Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis B.","volume":"6","author":"Fattovich","year":"1986","journal-title":"Hepatology"},{"key":"R15-14-20250326","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"R16-14-20250326","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"R17-14-20250326","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis.","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"R18-14-20250326","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1148\/91.6.1195","article-title":"Relationship between liver size and body size.","volume":"91","author":"Deland","year":"1968","journal-title":"Radiology"},{"key":"R19-14-20250326","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis, an update on terminology and reporting.","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R20-14-20250326","first-page":"101","article-title":"Distribution of 5 antigens in hepatocellular carcinoma.","volume":"41","author":"Thung","year":"1979","journal-title":"Lab Invest"},{"key":"R21-14-20250326","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.1840030505","article-title":"Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus.","volume":"3","author":"Hadziyannis","year":"1983","journal-title":"Hepatology"},{"key":"R22-14-20250326","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(76)80364-2","article-title":"Detection of e antigen and antibody: correlations with hepatitis B surface and hepatitis B core antigens, liver disease, and outcome in hepatitis B infections.","volume":"71","author":"Trepo","year":"1976","journal-title":"Gastroenterology"},{"key":"R23-14-20250326","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.1840010503","article-title":"Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver.","volume":"1","author":"Bonino","year":"1981","journal-title":"Hepatology"},{"key":"R24-14-20250326","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hep.1840070215","article-title":"Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases.","volume":"7","author":"Dragosics","year":"1987","journal-title":"Hepatology"},{"key":"R25-14-20250326","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(86)90395-1","article-title":"Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.","volume":"90","author":"Bonino","year":"1986","journal-title":"Gastroenterology"},{"key":"R26-14-20250326","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3349\/ymj.1996.37.5.295","article-title":"Peritoneoscopic liver biopsy findings in asymptomatic chronic HBsAg carriers with normal liver function tests and no hepatomegaly.","volume":"37","author":"Chon","year":"1996","journal-title":"Yonsei Med J"},{"key":"R27-14-20250326","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/0003-4819-118-3-199302010-00006","article-title":"The natural history of asymptomatic hepatitis B surface antigen carriers.","volume":"118","author":"de Franchis","year":"1993","journal-title":"Ann Intern Med"},{"key":"R28-14-20250326","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-8278(85)80759-5","article-title":"Detection of serum HBV-DNA by molecular hybridization: correlation with HBeAg anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.","volume":"1","author":"Karayiannis","year":"1985","journal-title":"J Hepatol"},{"key":"R29-14-20250326","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0168-8278(94)80115-0","article-title":"Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The investigators of the European Concerted Action on Viral Hepatitis (EUROHEP).","volume":"21","author":"Realdi","year":"1994","journal-title":"J Hepatol"},{"key":"R30-14-20250326","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hep.1840080310","article-title":"The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.","volume":"8","author":"Liaw","year":"1988","journal-title":"Hepatology"},{"key":"R31-14-20250326","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2003.10.050","article-title":"Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.","volume":"126","author":"Perrillo","year":"2004","journal-title":"Gastroenterology"},{"key":"R32-14-20250326","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.510310130","article-title":"Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B.","volume":"31","author":"Villeneuve","year":"2000","journal-title":"Hepatology"},{"key":"R33-14-20250326","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2004-812683","article-title":"Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.","volume":"42","author":"Wiegand","year":"2004","journal-title":"Z Gastroenterol"},{"key":"R34-14-20250326","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0168-8278(00)80371-2","article-title":"Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection.","volume":"33","author":"Yao","year":"2000","journal-title":"J Hepatol"},{"key":"R35-14-20250326","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/jhep.2001.26512","article-title":"Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.","volume":"34","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"R36-14-20250326","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir diovoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"R37-14-20250326","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"A one year trial of lamivudine for chronic hepatitis B.","volume":"339","author":"Lai","year":"1998","journal-title":"N Engl J Med"},{"key":"R38-14-20250326","first-page":"223","article-title":"Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis.","volume":"14","author":"Autschbach","year":"1991","journal-title":"Hepatology"},{"key":"R39-14-20250326","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1542-3565(04)00066-7","article-title":"Reversibility of cirrhosis in chronic hepatitis B.","volume":"2","author":"Malekzadeh","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R40-14-20250326","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1542-3565(03)00312-4","article-title":"A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.","volume":"2","author":"Keeffe","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R41-14-20250326","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3748\/wjg.v8.i6.1077","article-title":"Detection of soluble TRAIL in HBV infected patients and its clinical implications.","volume":"8","author":"Han","year":"2002","journal-title":"World J Gastroenterol"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20328","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200501000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T14:11:12Z","timestamp":1743257472000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200501000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20328","relation":{},"ISSN":["1527-6465"],"issn-type":[{"type":"print","value":"1527-6465"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}